Rotavirus-Adenovirus Combo Test Device

Call For Pricing.

Model Number: NH-45184

Brand: Niche Healthcare

The Rotavirus-Adenovirus Combo Rapid Test Device (Feces) is a rapid chromatographic immunoassay for the qualitat ive detection of Adenovirus and Rotavirus in feces. This kit is intended to be used as an aid in the diagnosis of adenovirus or rotavirus infection.



Catalog No. ROT-5022 Format Device
Specimen Feces Certificate None CE
Reading Time 15 minutes Test/Kit 40
Storage Temperature 4-30°C Shelf Life 2 Years
Sensitivity >99.9% Specificity >99.9%
Accuracy >99.9% Composition Test device, Specimen collection tube with buffer, Package insert, Desiccant


Here are potential benefits:

  1. Early Detection of Viral Infections: The rapid test allows for the early detection of rotavirus and adenovirus infections in fecal samples, enabling timely diagnosis and treatment.

  2. Prompt Initiation of Supportive Care: Early detection facilitates the prompt initiation of supportive care, including rehydration and symptomatic relief for patients with viral gastroenteritis caused by rotavirus or adenovirus.

  3. Isolation and Infection Control Measures: Identifying viral infections in fecal samples can prompt healthcare providers to implement appropriate isolation and infection control measures to prevent the spread of the viruses within healthcare settings.

  4. Reduced Antibiotic Usage: Rapid viral testing can help differentiate between viral and bacterial causes of gastroenteritis. This differentiation is essential for avoiding unnecessary antibiotic use, as antibiotics are ineffective against viral infections.

  5. Resource Optimization: Rapid tests contribute to efficient resource utilization by providing quick and cost-effective diagnostic information, allowing healthcare providers to prioritize and manage cases more effectively.

  6. Point-of-Care Testing: Rapid tests can be performed at the point of care, providing quick results without the need for sending samples to a laboratory. This expedites decision-making and allows for immediate supportive care initiation.

  7. Public Health Surveillance: Monitoring the prevalence of rotavirus and adenovirus infections in the population through rapid testing contributes to public health surveillance efforts. This information helps in planning and implementing preventive measures and public health interventions.

  8. Pediatric Health Management: Rapid testing is particularly valuable in pediatric healthcare, where rotavirus is a common cause of severe gastroenteritis in young children. Early diagnosis allows for appropriate management of pediatric cases.

  9. Reduced Hospitalizations: Timely detection of viral infections may contribute to reducing the severity of illness, minimizing complications, and potentially decreasing the need for hospitalizations.


Infectious Disease Trials

Infectious disease trials are conducted to address various aspects related to the prevention, treatment, and understanding of diseases caused by infectious agents, such as bacteria, viruses, parasites, or fungi. Here are some reasons for conducting infectious disease trials:

  1. Vaccine Development: Trials are crucial for testing the safety and efficacy of new vaccines aimed at preventing infectious diseases. This includes vaccines for viruses like influenza, human papillomavirus (HPV), and emerging threats like COVID-19.
  2. Antiviral and Antibiotic Testing: Clinical trials assess the effectiveness of new antiviral medications or antibiotics in treating infections. This is particularly important in addressing antibiotic resistance and finding alternative treatments.
  3. Understanding Disease Mechanisms: Trials help researchers understand the mechanisms of infectious diseases, including how pathogens spread, evade the immune system, and cause illness.
  4. Global Health Concerns: Trials play a vital role in addressing global health concerns, such as emerging infectious diseases (e.g., Ebola, Zika, COVID-19) and ongoing challenges like malaria, tuberculosis, and HIV.
  5. Public Health Interventions: Trials evaluate the effectiveness of public health interventions, such as strategies for disease prevention, control, and containment.
  6. Drug and Treatment Development: Researchers conduct trials to develop and test new drugs or treatment regimens for infectious diseases, aiming to improve outcomes for affected individuals.
  7. Surveillance and Epidemiology: Clinical trials contribute to surveillance efforts by providing data on disease prevalence, transmission patterns, and the effectiveness of control measures.

Infectious disease trials are essential for advancing our understanding of these diseases, developing effective interventions, and ultimately improving global public health. They contribute significantly to the development of evidence-based strategies for preventing, treating, and managing infectious diseases.


Types of Infections

Types of Infections


For more information, contact us 01274 965089 or check out our website at

Further clinical information can be found on our blog page:

For products not found on our online website, please view our Healthcare catalogues:

View our Healthcare YouTube videos Playlist

If you have any additional questions, drop us an email at 


There are no reviews yet.

Be the first to review “Rotavirus-Adenovirus Combo Test Device”

Your email address will not be published. Required fields are marked *